Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) de...

Daiichi pays Merck $170M to develop bronchi cancer cells T-cell engager deal

.Merck &amp Co. has actually promptly made back some of the prices of its own Javelin Therapeutics a...

BioMarin halts preclinical gene therapy for heart condition

.After BioMarin administered a spring well-maintained of its pipe in April, the provider has actuall...

Eisai plants molecular glue SEED along with $1.5 B biobucks handle

.Major Pharmas stay stuck to the suggestion of molecular adhesive degraders. The most recent firm to...

Life scientific research credit score firm reveals along with $600M

.A brand new international lifestyle scientific research credit history organization, referred to Sy...

BMS trenches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing one more large bet coming from the Caforio era, terminating a bargain...

Nuvation standstills wager inhibitor after thinking about stage 1 information

.After checking out at stage 1 data, Nuvation Biography has actually determined to stop deal with it...

' Scientific intuitiveness' led FDA experts to support Zevra's unusual ailment med

.Zevra Therapies' rare illness medication seems to be to be on the course to permission this autumn ...

Pfizer takes $230M reached after axing fell short DMD gene therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has blown a $230 million ...

AC Immune views 'spots' possible in Alzheimer's medicine information

.After more than 20 years of work with neurodegenerative health conditions, Swiss biotech air condit...